Medical Dosimetry
Volume 32, Issue 4 , Pages 281-286 , Winter 2007

Impact of Endorectal Balloon in the Dosimetry of Prostate and Surrounding Tissues in Prostate Cancer Patients Treated with IMRT

Presented at the 86th Scientific Assembly and Annual Meeting of Radiological Society of North America, Chicago, IL, 2000.

  • Maria T. Vlachaki, M.D., Ph.D., M.B.A.

      Affiliations

    • Wayne State University School of Medicine, Detroit, MI
    • Corresponding Author InformationReprint requests to: Maria T. Vlachaki, M.D., Ph.D, M.B.A., Wayne State University School of Medicine, Department of Radiation Oncology, 540 East Canfield, 1212 Scott Hall, Detroit, MI 48201.
    • ,
  • Terrance N. Teslow, Ph.D.

      Affiliations

    • Johns Hopkins School of Medicine, Baltimore, MD
    • ,
  • Salahuddin Ahmad, Ph.D.

      Affiliations

    • University of Oklahoma Health Sciences Center, Oklahoma City, OK

Received 19 February 2007 ,Accepted 21 February 2007.

References 

  1. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1998;41:491–500
  2. Kupelian PA, Buchsbaum JC, Reddy CA, et al. Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6 and pretreatment prostate-specific antigen < or = 10). Int. J. Radiat. Oncol. Biol. Phys. 2001;50:621–625
  3. Hanks GE, Martz KL, Diamond JJ. The effect of dose on local control of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1988;15:1299–1305
  4. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: Results of the M.D (Anderson phase III randomized trial). Int. J. Radiat. Oncol. Biol. Phys. 2002;53:1097–1105
  5. Storey MR, Pollack A, Zagars GK, et al. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 2000;48:635–642
  6. Jackson A, Skwarchuk MW, Zelefsky MJ, et al. Late rectal bleeding after conformal radiotherapy of prostate cancer (II. Volume effects and dose-volume histograms). Int. J. Radiat. Oncol. Biol. Phys. 2001;49:685–698
  7. Ten Haken RK, Forman JD, Heimburger DK, et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int. J. Radiat. Oncol. Biol. Phys. 1991;20:1317–1324
  8. Roeske JC, Forman JD, Mesina CF, et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1995;33:1321–1329
  9. Schild SE, Casale HE, Bellefontaine LP, et al. Movements of the prostate due to rectal and bladder distension: Implications for radiotherapy. Med. Dosim. 1993;18:13–15
  10. Padhani AR, Khoo VS, Suckling J, et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int. J. Radiat. Oncol. Biol. Phys. 1999;44:525–533
  11. Langen KM, Jones DTL. Organ motion and its management. Int. J. Radiat. Oncol. Biol. Phys. 2001;50:265–278
  12. Antolak JA, Rosen II, Childress CH, et al. Prostate target volumes variations during a course of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1998;42:661–672
  13. Roach M, Faillace-Akazawa P, Malfatti C. Prostate volumes and organ movement defined by serial computerized tomographic scans during three-dimensional conformal radiotherapy. Radiat. Oncol. Invest. 1997;5:187–194
  14. Lattanzi J, McNeeley S, Pinover W, et al. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1999;43:719–725
  15. Lattanzi J, McNeeley S, Donnelly S, et al. Ultrasound-based stereotactic guidance in prostate cancer-quantification of organ motion and set-up errors in external beam radiation therapy. Comput. Aid. Surg. 2000;5:289–295
  16. Vigneault E, Pouliot J, Lavadiere J, et al. Electronic portal imaging device detection of radiopaque markers for the evaluation of prostate position during megavoltage irradiation: A clinical study. Int. J. Radiat. Oncol. Biol. Phys. 1997;37:205–212
  17. Shimizu S, Shirato H, Kitamura K, et al. Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers. Int. J. Radiat. Oncol. Biol. Phys. 2000;48:1591–1597
  18. Mohan DS, Kupelian PA, Willoughby TR. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. Int. J. Radiat. Oncol. Biol. Phys. 2000;46:575–580
  19. Teh BS, Woo SY, Mai WY, et al. Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilization. Med. Dosim. 2002;27:105–113
  20. McGary JE, Teh BS, Butler EB, et al. Prostate immobilization using a rectal balloon. J. Appl. Clin. Med. Phys. 2002;3:6–11
  21. Teh BS, Dong L, McGary JE, et al. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity modulated radiation therapy (IMRT) for prostate cancer. Med. Dosim. 2005;30:25–30
  22. Carol MP. Beam modulation conformal radiotherapy. In:  Purdy JA,  Emami B editor. 3D Radiation Treatment Planning and Conformal Therapy. Madison, WI: Advanced Medical Publishing; 1993;p. 435–445
  23. Grant WH. Experience with intensity modulated beam delivery. In:  Mackie TR,  Palta JR editor. Teletherapy: Present and Future. Madison, WI: Advanced Medical Publishing; 1996;p. 793–804
  24. Sternick ES, Carol MP, Grant WH. Intensity modulated radiotherapy. In:  Khan FM,  Potish RA editor. Treatment Planning in Radiation Oncology. Baltimore: Williams and Wilkins; 1998;p. 187–213
  25. McGary JE, Grant WH. A clinical evaluation of set-up errors for a prostate immobilization system. J. Appl. Clin. Med. Phys. 2000;1:138–147
  26. Ahmad S, Vlachaki MT, Teslow TN, et al. Impact of setup uncertainty in the dosimetry of prostate and surrounding tissues in prostate cancer patients treated with Peacock/IMRT. Med. Dosim. 2005;30:1–7
  27. Ahmad S, Vlachaki MT, et al. Impact of margin on tumor and normal tissue dosimetry in prostate cancer patients treated with IMRT using an endorectal balloon for prostate immobilization. Austral. Phys. Eng. Sci. Med. 2005;28:209–215
  28. Teh BS, Mai WY, Uhl BM, et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: Acute toxicity and dose-volume analysis. Int. J. Radiat. Oncol. Biol. Phys. 2001;49:705–712
  29. Sanghani M, Ching J, Schultz D, et al. Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy. Urol. Oncol. 2004;22:165–168
  30. Wachter S, Gerstner N, Dorner D, et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002;52:91–100
  31. Patel R, Orton N, Tome W, et al. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiother. Oncol. 2003;65:285–294
  32. Teh BS, Bastasch MD, Wheeler TM, et al. IMRT for prostate cancer defining target volume based on correlated pathologic volume of disease. Int. J. Radiat. Oncol. Biol. Phys. 2003;56:184–191
  33. Diaz AZ, Roach M, Marquez C, et al. Indications for and significance of including the seminal vesicles during 3D conformal radiotherapy in men with clinically localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1996;30:323
  34. Marks LB, Carroll PR, Dugan TC, et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1995;31:1257–1280
  35. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and then European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys. 1995;31:1341–1346
  36. Wachter S, Gerstner N, Goldner G, et al. Rectal sequelae after conformal radiotherapy of prostate cancer: Dose-volume histograms as predictive factors. Radiother. Oncol. 2001;59:65–70

PII: S0958-3947(07)00051-9

doi: 10.1016/j.meddos.2007.02.007

Medical Dosimetry
Volume 32, Issue 4 , Pages 281-286 , Winter 2007

Article Tools

* Image Usage & Resolution